Molina Healthcare beats expectations on disciplined cost management

Published: 2026-04-23 11:49:11 ET MOH

Molina Healthcare has reported Q1 results that exceeded expectations, bolstered by effective medical cost management. The group posted adjusted EPS of $2.35, compared to the $1.92 anticipated by analysts, sending the stock up more than 14% during trading. This performance was driven notably by an increase in enrollment in its state-funded plans, boosting premium revenue.

Esteban Tesson

Published on 04/23/2026 at 11:49 am EDT

Revenue came in at $10.8bn, slightly below market expectations, but this weakness was offset by better control of healthcare spending. The medical cost ratio reached 91.1%, marginally higher than estimates, illustrating moderate pressure on expenses despite rising demand for certain procedures.The group reaffirmed its 2026 outlook, targeting approximately $42bn in premium revenue and annual adjusted EPS of at least $5. Specializing in Medicaid programs and Obamacare-related offerings, Molina is benefiting from momentum comparable to that of its peers. However, the company plans to exit the Medicare Advantage prescription drug segment starting in 2027, citing underperformance.